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This paper sheds new light on the impact of AIDS on cross-country income levels. Our
empirical analysis uses data for 89 countries spanning the period 1979 to 2000 during which
AIDS has spread across the world. We control for a variety of factors that are potentially
related to income as suggested by our empirical model and existing related literature. Using the
extended (for human capital) Solow model as our baseline empirical speciﬁcation, we consider
cross-sectional and panel estimation. For the full sample it is shown that AIDS has a negative
and signiﬁcant eﬀect on the level of income in both the cross-sectional, and panel estimations.
In addition, using data on age groups we ﬁnd that only the AIDS coeﬃcient corresponding to
the age group 16-34 is signiﬁcant and obtains a negative sign. When we arbitrarily split our
full sample into OECD and non-OECD countries, we ﬁnd that the AIDS coeﬃcient continues
to be negative and signiﬁcant for the non-OECD subsample but not for the OECD subsample.
Finally, using Hansen’s (2000) endogenous splitting methodology we ﬁnd evidences in favor of
AIDS as a threshold variable. Our main quantitative result is that an increase in AIDS incidence
by 1 in 100,000 people is associated with a 0.003% − 0.004% reduction in income per worker.
Keywords: AIDS incidence, AIDS incidence by age group, cross-country per worker income,
cross-sectional and panel estimation, country heterogeneity.
JEL Classiﬁcation: O30, O40, O47
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1I n t r o d u c t i o n
The World Heath Organization (WHO) estimated that in December 2002, 42 million people were
living with the human immunodeﬁciency virus (HIV) or the acquired immune deﬁciency syndrome
(AIDS). The newly infected with HIV in 2002 totaled 5 million and AIDS related deaths in 2002
were 3.1 million. HIV/AIDS now ranks as the world’s fourth largest cause of death, after heart
disease, strokes and acute lower respiratory infections (Dixon, McDonald, Roberts (2002)).1 It is
feared that AIDS will soon surpass malaria, which has been around for at least a millennium, and
considered as the most deadly infectious disease. AIDS may be a relatively new infectious disease,
only quarter of a century old, but its negative impact is felt most profoundly in sub-Saharan Africa
in which it is erasing decades of progress made in extending quantity and improving quality of life.2
AIDS’ alarming infection rate coupled with no known cure has very important social, political,
demographic and certainly economic implications. A central point of analysis for economists is to
evaluate the impact of AIDS on economic welfare and in particular on per capita income. There is
a small but rapidly expanding literature related to the economic eﬀects of AIDS. Several theoretical
papers suggest large negative economic consequences of the pandemic. For example, Cuddington
(1993), simulating a modiﬁed Solow model, concluded that AIDS, via its impact on morbidity and
mortality rates, would likely reduce GDP in Tanzania in 2010 by 15 to 20 percent relative to a
counterfactual of no-AIDS scenario. Similarly, Cuddington and Hancock (1994) using a similar
methodology simulated the impact of AIDS on the Malawian economy and found that the average
annual real per capita GDP growth over the 1985-2010 period is projected to be 0.2-0.3 percentage
points lower compared to the alternative no-AIDS scenario.
More recently, Ferreira and Pessoa (2003) have proposed a model in which AIDS impacts
negatively on income by aﬀecting the incentives for schooling attainment due to shorter expected
longevity. Based on their model, the most aﬀected countries in sub-Saharan Africa are predicted to
become about 25 percent poorer than they would have been without AIDS, with schooling declining
by about 50 percent. Finally, Corrigan, Glomm, and Mendez (2003) constructed and fully studied
a model that exhibited substantial negative growth eﬀects of the AIDS epidemic, mainly through
1For a very insightful introduction to AIDS and the various ways that is embedded within social, cultural, political,
ideological and economic contexts see the book by Kalipeni et al. (2004). Extensive information on the AIDS epidemic
and its economic consequences is available online at: http://www.worldbank.org/aids-econ/.
2Average life expectancy at birth in sub-Saharan countries is now 47 years, when according to experts it could
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the detrimental impact of lower life expectancy on investment combined with a sizable number of
orphans created by AIDS. Even though the above papers have contributed to our understanding of
the problem, they are based on theoretical models that are taken to the data by means of numerical
simulation exercises and do not utilize the full information that potentially exists in existing AIDS
data.3
At the empirical side, the little work that exists has focused on the use of mirco data — at the
village or country level; see e.g. Wachter, Knodel and VanLandingham (2003), de Walque (2004),
and Young (2004).4,5 An exception is an important contribution by Bloom and Mahal (1997).
These authors use standard epidemiological models to estimate the number of AIDS incidents
from information on HIV prevalence at a point in time. Utilizing their rather scarce cross-country
estimates of AIDS incidents and using novel econometric techniques these authors arrive to the
conclusion that the AIDS epidemic has had an insigniﬁcant eﬀect on the growth rate of per capita
income.
The main goal of this paper is to provide new evidence on the potential eﬀect of AIDS on
cross-country income. In principle this paper follows the lead of Bloom and Mahal (1997) and
makes a contribution to the embryonic literature that studies empirically the potential impact of
AIDS on economic aggregates. There are two main diﬀerences between our work and that of Bloom
and Mahal relating to the focus of the analysis and t h ed a t au s e di ne s t i m a t i o n .F i r s t ,i no r d e rt o
address the economic implications of the disease on welfare, our framework focuses on levels rather
than growth of per capita income.6 Second, we use an alternative more comprehensive dataset on
oﬃcially reported AIDS cases compiled by WHO and UNAIDS for the period 1979-2000 across 116
countries. This enables us to consider both cross-sectional regression and panel techniques to study
the impact of the disease on the level of income.
In particular, our empirical analysis is based on the extended (for human capital) Solow spec-
3Other recent notable theoretical papers include Levy (2002), Auld (2003), Clark and Vencatachellum, and Oster
(2004).
4In his interesting and highly controversial paper, Young (2004) attempts to calculate the impact of the AIDS
epidemic on future living standards in South Africa. He concludes that from the perspective of per capita living
standards, the AIDS epidemic endows society with additional resources which in turn could be used to care for the
aﬄicted and provide higher living standards to future generations.
5For updates on recent academic and nonacademic papers, surveys, and ﬁeld studies on HIV/AIDS in developing
countries visit the website of the International AIDS Economics Network at: http://www.iaen.org/papers/.
6For this and other arguments in favor of using levels rather than growth regressions, see Hall and Jones (1999,
pp. 85-86). Others papers that use level regressions include Frankel and Romer (1999), Acemoglu, Johnson and
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iﬁcation. Making use of Penn World Table version 6.1 we extend the Mankiw, Romer and Weil
(1992) (MRW hereafter) dataset until the year 2000 and consequently merge this dataset with our
AIDS dataset. We obtain results using cross-sectional and panel techniques based on the extended
Solow model with AIDS as an additional explanatory variable. In addition, we employ the data
splitting methodology proposed by Hansen (2000) to examine whether AIDS is a valid threshold
variable that can cluster countries into groups obeying diﬀerent statistical models.
Our main ﬁndings are as follows: First, we show that AIDS incidents has a negative and
signiﬁcant eﬀect on the level of income for the full sample in both the cross-sectional and panel
estimations. When we arbitrary split our full sample into OECD and non-OECD countries, we ﬁnd
that the AIDS coeﬃcient continues to be negative and signiﬁcant for the non-OECD subsample,
but not for the OECD subsample. Second, exploiting a nice feature of our dataset that allows
us to disaggregate the data in four diﬀerent age groups, we ﬁnd that only the AIDS coeﬃcient
corresponding to the age group 16-34 is negative and signiﬁcant. Third, when we use Hansen’s
(2000) endogenous splitting methodology, we ﬁnd that AIDS is a threshold variable that can split
countries into regimes that obey diﬀerent statistical models. Finally, robustness analysis shows
that our results are quite robust to diﬀerent subsamples and regression speciﬁcations.
The remainder of the paper is organized as follows. Section 2 takes a ﬁrst look at the AIDS data
used in our empirical analysis. Section 3 presents our baseline cross-sectional and panel estimation
results for the full sample and various exogenously and endogenously determined subsamples of
countries. Section 4 examines the robustness of our baseline results by considering alternative
subsamples and regression speciﬁcations. Section 5 discusses of our main results with particular
emphasis in interpretation, and potential caveats of our analysis. Section 6 concludes.
2A L o o k a t t h e D a t a
We begin by describing the AIDS data used in our estimation. Later on,we explain how we update
the MRW original dataset to obtain the rest of the data needed for our analysis. The datasets used
in this paper (cross-section, panel and age-speciﬁc) are available in their entirety from the authors
upon request.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 4
2.1 The AIDS dataset
We constructed the AIDS dataset which includes 116 countries over 1979-2000 using the oﬃcially
reported cases from the UNAIDS/WHO Global Surveillance fact sheets.7 The WHO “case” def-
inition for AIDS surveillance is as speciﬁed in “Weekly Epidemiological Record,” WHO, Geneva
(1994).8 For each country in the sample we start from the year during which a case was reported.
We multiply the number of reported incidents by 100,000 and divide by total population in each
year (data on population is from the World Development Indicators (2002)) to obtain incidence
per 100,000 per country per year. The oﬃcially reported AIDS cases represent the number of new
AIDS infections, occurring each year. Thus, we obtain AIDS incidence, which is a ﬂow measure.
Due to data constraints associated with explanatory variables necessary for our empirical analysis
other than AIDS, our sample is reduced from 116 countries to 89.9 Regarding the cross-sectional
estimation, for each country in the sample we average AIDS incidents, starting from the year in
which a case was reported (usually 1979) up to the year 2000. For the panel estimation, we aver-
age the data into 5 year periods for which the disturbance terms are less likely to be inﬂuenced
by business cycle ﬂuctuations. Thus, we construct three non-overlapping ﬁve-year time intervals
1985-1990, 1990-1995 and 1995-2000.
N e x t ,w et a k eaﬁrst look at the AIDS dataset by presenting correlations and descriptive sta-
tistics at the regional and country levels. In addition, we exploit a nice feature of our dataset
and disaggregate our data into AIDS incidents by four age groups (0-4, 5-15, 16-34, 35-60+). We
present examples from this disaggregated dataset for selected countries.
Table 1 presents the mean, standard deviation, minimum and maximum of AIDS and mean
GDP per worker for ﬁve regions and the world.10 The main reason for grouping countries into
7Of note is the exclusion of South Africa from our dataset due to the gross under-reporting observed and docu-
mented by many ﬁeld researchers. We thank participants at the North East Universities Development Consortium
(NEUDC) 2004 conference and in particular Mark Gersovitz, Damien de Walque, D´ esir´ e Vencatachellum, for their
insights on the substantial measurement errors present in the South African AIDS dataset.
8For a detailed description of the deﬁnition, see Appendix B.
9More on the sample used in our empirical estimation later on. For more informa t i o na b o u tt h es a m p l eo fc o u n t r i e s
and relevant variables used in the estimation, see Appendix A, Table A1.
10Africa: Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, C. African Rep., Chad, Comoros,
Congo, Egypt, Gabon, Gambia, Ghana, Guinea, Guinea-Bis., Kenya, Lesotho, Madagascar, Malawi, Mali, Maurita-
nia, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, Seychelles, Sierra Leone, Sudan,
Swaziland, Tanzania, Togo, Tunisia, Uganda, Zambia, Zimbabwe. Americas: Argentina, Barbados, Bolivia, Brazil,
Canada, Chile, Colombia, Costa Rica, Dominican Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras,
Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Tri.&Tobago, USA, Uruguay, Venezuela. Asia: Bangladesh,
China, Cyprus, Hong Kong, India, Indonesia, Iran, Israel, Japan, Jordan, Korea, Malaysia, Oman, Pakistan, Philip-
pines, Saudi Arabia, Singapore, Sri Lanka, Syria, Thailand, Turkey, Yemen. Europe: Austria, Belgium, CzechWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 5
Table 1: Regional descriptive statistic
Regions Variable Mean Stand. Dev. Min. Max.
Africa GDP per worker ($) 2195 2395 461 10294
AIDS cases per 100,000 22.317 37.632 0.021 173.043
Americas GDP per worker ($) 6192 5234 1075 22934
AIDS cases per 100,000 6.326 6.734 0.217 26.818
Asia GDP per worker ($) 7951 6799 1004 21205
AIDS cases per 100,000 1.129 3.596 0.001 17.047
Europe GDP per worker ($) 15322 5595 4424 29274
AIDS cases per 100,000 2.046 2.127 0.022 8.412
Oceania GDP per worker ($) 10566 7855 3152 19424
AIDS cases per 100,000 1.433 1.120 0.162 2.872
W o r l d G D Pp e rw o r k e r( $) 7153 6888 461 29274
AIDS cases per 100,000 9.938 24.355 0.001 173.043
Notes: The mean, standard deviation, minimum and maximum values presented above are computed
for 41 countries in Africa, 25 countries in the Americas, 22 countries in Asia, 24 countries in Europe, 4
countries in Oceania. GDP per worker and AIDS incidents represent averages since an AIDS case was
reported annually from 1979 until 2000.
regions is to examine whether geographical location matters. We note that the mean for AIDS in
Africa (22.317) is much higher than in all other regions/continents. Another interesting observation
is the quite high incidence of AIDS in the Americas (with mean 6.326). It is much higher than
in Europe, where the mean incidence of AIDS is 2.016. Finally, it is readily seen that Asia and
Oceania are experiencing considerably lower AIDS incidents than Africa, the Americas and Europe
even though, as the standard deviation reveals, there also exists substantial variation between
countries in these regions. The world mean AIDS incidents is quite large at 9.938 but obviously
upward biased by the African subsample.
Figure 1 adds a dynamic element to the descriptive statistics of Table 1 by illustrating the
rate by which the infectious disease spread in each region. Three features stand out in Figure 1.
First, is the rapid spread of the disease in Africa. This is a concern that is well-documented in the
literature and echoed loudly in the public media. Second, is the observed reversal of AIDS spread
R e p u b l i c ,D e n m a r k ,F i n l a n d ,F r a n c e ,G r e e c e ,H u n g a r y ,I c e l and, Ireland, Italy, Luxembourg, Netherlands, Malta,
Norway, Poland, Portugal, Romania, Russian Fed., Slovakia, Spain, Sweden, Switzerland, UK. Oceania: Australia,
Fiji, New Zealand, Papua N.G..What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 6

































AIDS incidents per continent
Notes: This plot illustrates the evolution of AIDS in 5 regions over the period 1979-2000.
rate in Africa and Latin America after 1997, and in Europe after 1995. A plausible explanation for
this slowdown is that policies and educational programs for promoting AIDS awareness initiated
by many local, national and international agencies may have started to pay oﬀ. Third, is the recent
increase in AIDS incidence in Asia. This is a major concern because AIDS in particular South
Asian countries (i.e. Thailand and China) have increased at an alarming rate over the last few
years.
Next, we present AIDS incidents for individual countries to highlight the great variation that
exists among them. Table 2 presents the top and bottom 25 countries in our sample of 116 countries.
Among the countries with highest AIDS incidents 20 are located in sub-Saharan Africa. This
speaks directly to the major concerns raised by international organizations, such as the World
Bank, WHO and UN, and governments of advanced nations like the U.K., Germany and the U.S.11
It is interesting to notice however that the U.S. and Thailand are also part of the top 25 list.
This suggests that AIDS may be diﬀerent from other determinants of economic development that
typically are inherently dependent on per worker income. This argument is reinforced by looking at
11For example, during their campaign for the November 2004 U.S. presidential election both president Bush and
senator Kerry highlighted AIDS in sub-Saharan Africa as one of the most stressing socioeconomic and humanitarian
problems of modern times.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 7
Table 2: Countries with highest and lowest AIDS incidents
Top 25






Lesotho∗ 54 9 .333
Malawi 6 40.971
Zambia 7 39.767

















Burkina Faco 25 13.589
Bottom 25










Czech Rep.∗ 100 0.096
Japan 101 0.095
India 102 0.073
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Chad Honduras Tanzania Thailand Togo USA
Source: WHO(2002)
in selected countries
AIDS incidents by age group
0-4 5-15
16-34 35-60+
Notes: This ﬁgure illustrates AIDS incidents by age group. We were able to assemble a dataset with
6 3c o u n t r i e sf o rw h i c hA I D Si n c i d e n t sc o u l db ed i ssagregated into four age groups. For details see
Appendix C.
the list with the bottom 25 countries as many developing and less developed countries experience
very low AIDS incidents. A notable feature of the low-AIDS-incidence list is that the primary
religion in 12 out of the 25 countries is Islam. This is consistent with the hypothesis that religion
may be inﬂuential to the culture of these countries keeping AIDS incidents very low.
Finally, we take advantage of a nice feature of our dataset and present AIDS incidents by four
diﬀerent age groups for selected countries. This disaggregation reveals that there is signiﬁcant
variability in the way AIDS aﬀects diﬀerent age groups across countries. For example, Figure 2
illustrates that for countries like the U.S., Togo and Chad the most aﬀected age group is 35-60+
whereas for Tanzania, Thailand and Honduras the most aﬀected age group is 16-34. This variability
is explored further in our empirical analysis.
2.2 Extending the MRW dataset
Since our empirical analysis is based on the Solow speciﬁcation, we have extended the MRW
original dataset (PWT version 4.0) until the year 2000 for their non-oil sample. Our data sources
are the World Development Indicators (WDI-2002) for working age population growth, Barro andWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 9
Lee (2001) and Bernanke and G¨ urkaynak (2001) for human capital, and PWT version 6.1 for the
remaining variables. Due to data constraints with variables necessary for our estimation other
than AIDS, our sample was reduced from 116 to 89 countries (our sample is reduced further to 81
countries in the panel estimation).
It is important to clarify that for human capital we use the Bernanke and G¨ urkaynak datatset12
for our cross-sectional estimation and the Barro and Lee dataset for our panel estimation. We do
that because the former dataset oﬀers more observations for our cross-sectional estimation, whereas
the latter dataset oﬀers more entries for our panel estimation.
3 Estimation and Results
In this section we present our baseline results. First, we present the cross-sectional results for the
full sample and arbitrarily chosen subsamples as well as endogenously chosen subsamples.
3.1 Cross-sectional estimation
Our empirical analysis is based on the extended unrestricted Solow speciﬁcation in which we con-
sider AIDS as a productivity shock. Speciﬁcally, we consider the following regression equation:
lnyi,2000 = a0 + a1 lnsik + a2 ln(ni + g + δ)+a3 lnsih + a4AIDSi + εi, (1)
where yi,2000 is output per working age person in country i in 2000,13 sik is the ratio of average
investment to GDP over 1979-2000, sih is secondary school enrollment of working-age population,
ni is average population growth, g+δ =0 .05 as in MRW, AIDSi is the AIDS incidence per 100,000
people averaged for the period 1979-2000, and ε is an error term.14
Table 3 presents estimates for the extended Solow model for the period 1979-2000 for the full
sample and arbitrarily chosen OECD and non-OECD subsamples using ordinary least squares
(OLS). First, we estimate the MRW speciﬁcation with our extended data. These results are con-
sistent with MRW using data from PWT 4.0 for the period 1960-1985. They are also qualitatively
similar to Bernanke and G¨ urkaynak (2001) who extend the data until 1995, using PWT 6.0. Next
we add AIDS as a regressor, therefore treating it as a productivity parameter.
12Bernanke and G¨ urkaynak (2001) follow MRW and obtain their human capital measure by multiplying the fraction
of population in the ages of 12-17 that is enrolled in secondary school by the fraction of the working-age population
that is of school age (15-19). We average human capital for the period 1970-1995.
13Results are insensitive to using output per capita.
14Following Gallup and Sachs (2000) and McCarthy, Wolf and Wu (2002), AIDSi enters the regressions in levels.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 10
Table 3: Cross-country regressions for the full sample and OECD and non-OECD subsamples
Dependent variable: ln(GDP per worker in 2000)
Speciﬁcation Extended Solow Model Extended Solow Model with AIDS
(PWT 6.1) (PWT 6.1 − WHO 2002)
Non-oil OECD Non-OECD Non-oil OECD Non-OECD
Constant 4.7111∗∗∗ 10.2405∗∗∗ 5.9796∗∗∗ 4.8387∗∗∗ 10.0434∗∗∗ 6.1577∗∗∗
(0.9751) (2.0989) (1.6396) (0.9673) (2.0069) (1.6224)
lnsik 0.6190∗∗∗ 0.4973 0.5893∗∗∗ 0.6040∗∗∗ 0.5142 0.5732∗∗∗
(0.1276) (0.3342) (0.1396) (0.1281) (0.3173) (0.1401)
ln(ni + g + δ) −2.7775∗∗∗ −1.3014∗ −2.2274∗∗∗ −2.7292∗∗∗ −1.3294∗∗ −2.1595∗∗∗
(0.3094) (0.6683) (0.6366) (0.3062) (0.5799) (0.6290)
lnsih 0.6283∗∗∗ 1.2455∗∗∗ 0.6060∗∗∗ 0.6289∗∗∗ 1.2162∗∗∗ 0.6067∗∗∗
(0.0789) (0.3071) (0.0832) (0.0755) (0.2401) (0.0801)
AIDS −0.0031∗ 0.0247 −0.0032∗
(0.0019) (0.0174) (0.0020)
Adj. R2 0.849 0.584 0.724 0.852 0.653 0.731
Obs. 89 21 68 89 21 68
Notes: Standard errors are in parentheses. It is assumed that g +δ =0 .05 as in MRW. All regressions
are estimated using OLS. White’s heteroskedasticity correction was used.
∗∗∗ Signiﬁcantly diﬀerent
from 0 at the 1% level.
∗∗ Signiﬁcantly diﬀerent from 0 at the 5% level.
∗ Signiﬁcantly diﬀerent from
0 at the 10% level. Investment and population growth rates are averages for the period 1979-2000. sh
is the average percentage of the working-age population in secondary school for the period 1970-1995.
When we reestimate the MRW speciﬁcation using PWT 6.1 for the full sample of 89 countries,
we ﬁnd that the model explains 84.9% of the overall variation in per worker income (column 2).
Adding AIDS into the regression improves Adj. R2 slightly to 85.2% (column 5). The estimates
from the two models have the expected signs, but diﬀer a bit in magnitude. The estimated coeﬃcient
for physical capital decreases from 0.6190 in the model without AIDS to 0.6040 in the model with
AIDS, keeping the same signiﬁcance level at 1%. The coeﬃcient for human capital remains almost
identical in magnitude at 0.63 in both models and signiﬁcant at 1%. The estimated coeﬃcient
for ln(ni + g + δ)i s−2.7775 in the model without AIDS and increases to −2.7292 in the model
with AIDS, remaining highly signiﬁcant at the 1% level. Most importantly, for our full sample
the estimated coeﬃcient on AIDS is negative (−0.0031) and signiﬁcantly diﬀerent from zero at the
10% level. This result suggests that each additional AIDS incident per 100,000 people per year is
associated with a 0.0031 percentage point reduction in per worker income. This is ﬁrst evidenceWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 11
that AIDS has a negative impact on cross-country income.
Next, we examine our results by arbitrarily splitting the full sample into OECD and non-
OECD countries. In the model without AIDS, for the non-OECD countries, we obtain a positive
and highly signiﬁcant coeﬃcient for ln(sik), 0.5893, a positive and highly signiﬁcant coeﬃcient for
ln(sih), 0.6060, and a negative and signiﬁcant coeﬃcient for ln(ni + g + δ), −2.2274 (column 4).
There is little change in the coeﬃcient estimates between the speciﬁcation with and without AIDS
(column 7). What is important to notice is that the coeﬃcient estimate for AIDS remains negative
(−0.0032) and signiﬁcant at the 10% level.
When we compare the coeﬃcient estimates from the models without and with AIDS for the
OECD countries (columns 3 and 6, respectively) we ﬁnd that the coeﬃcient on sik increases from
0.4973 to 0.5142, but remain insigniﬁcant. The coeﬃcient on sih remains almost identical in terms
of magnitude (1.2) and highly signiﬁcant. The estimated coeﬃcient for ln(ni+g+δ)i s−1.3014 and
signiﬁcant at the 10% level in the model without AIDS, and decreases to −1.3294 and signiﬁcant
at the 5% level when we include AIDS. The estimated coeﬃcient for AIDS (quite surprisingly)
changes sign but is insigniﬁcant, suggesting that the epidemic has no signiﬁcant impact on the level
of income for developed countries.15
A possible explanation for this result may be that AIDS in non-OECD countries aﬀects those in
their most productive ages who can not aﬀord treatment. More precisely, since people in advanced
countries can aﬀord treatment using antiretroviral drugs, this can increase productivity, delay the
transmission of the disease, and potentially cause positive externalities by protecting other people.16
In developing countries, the eﬀect of the pandemic may be diﬀerent. People cannot aﬀord the
expensive drugs and because of the very low level of education, they are not even familiar with the
basic protection measure — the use of a condom. Kalemli-Ozcan (2004) provides new evidence on
the empirical relationship between the mortality rate changes and the quality-quantity trade-oﬀ for
a panel of African countries, where parents choose to have more children and provide them with
15We have also reestimated all of the speciﬁcations in Table 3 excluding Botswana, Congo, Malawi, Zimbabwe and
Zambia (the countries in our sample with the highest concentration of the epidemic). Results from this exercise appear
in Figure D1 and Table D1 in Appendix D. The main result is that when we exclude these countries with highest
AIDS incidence, the coeﬃcient estimate for AIDS remains negative and increases in magnitude and signiﬁcance for
the non-OECD subsample.
16However, the impact of antiretrovirals on the spread of the epidemic is yet unclear (Kremer (2002)). Advocates
of antiretroviral drugs for HIV/AIDS support the view that the eﬀect of these drugs is expected to lead to prevention
and slowdown of transmission. Alternatively, there exists the possibility that due to the availability of such drugs
people choose to have more and riskier sexual contacts.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 12
less education facing a high probability of getting infected with AIDS.
3.2 Panel estimation
This section extends our baseline cross-sectional results to consider estimation of the extended
Solow equation using panel data techniques. Even thought AIDS data since 1979 exists for some
countries in our sample, we consider the period 1985-2000 because for most countries 1985 was the
starting year for reporting AIDS incidents. This enables us to evaluate the impact of the epidemic
across diﬀerent countries and over time. Following much of the literature on cross-country panel
estimation, we average the data in ﬁve-year time intervals; 1985-1990, 1990-1995 and 1995-2000.
Due to data constraints our full sample is now reduced to 81 countries with a maximum of three and
a minimum of one time observations for each country. Our panel dataset is therefore unbalanced
with a total of 238 observations.
Our regression equation is:
lnyit = a0 + a1 lnsitk + a2 ln(nit + g + δ)+a3 lnsith + a4AIDSit + εit, (2)
where lnyit is income per worker and i =1 ,2,...,81 indexes each country and t =0 ,1,2 indexes
time-year periods, sitk is the ratio of average investment to GDP, sith is investment in human,17 nit
is the average population growth of the working age population, and g+δ is assumed as previously
to be 0.05. As in the cross-country regressions, we add AIDS in the panel regressions.
Table 4 presents results from the panel data analysis for the full sample under diﬀerent speci-
ﬁcations. First we consider the Between Estimator (BE).18 In a recent paper Hauk and Wacziarg
(2004) argue that using an OLS estimator applied to a single cross-section of variables averaged
over time (BE) performs best in terms of the extent of bias on each of the estimated coeﬃcients.
Consistent with the cross-sectional analysis, the coeﬃcient on AIDS is −0.0050 and signiﬁcant at
the 5% level (column 2). The remaining estimated coeﬃcients for ln(sitk), ln(nit+g+δ)a n dl n ( sith)
have the expected signs and are signiﬁcant at the 1% level.
To allow for the possibility of time eﬀects, we have also estimated the model by adding (T −1)
17Our measure of human capital is taken from Barro and Lee (2001) and is the percentage of secondary school
attained in the total population. We use the Barro and Lee (2001) human capital dataset (instead of the Bernanke-
G¨ urkaynak (2001) dataset) which provides data for ﬁve-year periods from 1960-2000 for most (81) of the countries
in our sample.
18We refer the interested reader to Green (2000, Ch.14, pp. 562-565) for further information on the Between
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Table 4: Panel regressions
Dependent variable: ln(GDP per worker for 1985-1990, 1990-1995 and 1995-2000)
Speciﬁcation Extended Solow Model with AIDS
(PWT 6.1 − WHO 2002)
Non-oil with Non-oil with Non-oil with Non-oil with Non-oil with
Between time eﬀects time eﬀects & dOECD & time eﬀects,
Estimator country eﬀects interaction term dOECD &
interaction term
Constant 6.0352∗∗∗ 6.6639∗∗∗ 7.9758∗∗∗ 8.8015∗∗∗ 8.7002∗∗∗
(1.0192) (0.5649) (0.3246) (0.6604) (0.6330)
lnsitk 0.6714∗∗∗ 0.6524∗∗∗ −0.0710 0.5462∗∗∗ 0.5592∗∗∗
(0.1113) (0.0664) (0.0505) (0.0666) (0.0638)
ln(ni + g + δ) −1.9045∗∗∗ −1.5976∗∗∗ −0.0375 −0.7212∗∗∗ −0.6996∗∗∗
(0.3462) (0.1920) (0.1051) (0.2480) (0.2374)
lnsith 0.5218∗∗∗ 0.5318∗∗∗ −0.3727∗∗∗ 0.5350∗∗∗ 0.5161∗∗∗
(0.0795) (0.0514) (0.0943) (0.0498) (0.0479)
AIDSit −0.0050∗∗ −0.0045∗∗∗ −0.0008 −0.0040∗∗∗ −0.0046∗∗∗









Adj. R2 0.84 0.81 0.45 0.82 0.84
Obs. 81 238 238 238 238
Notes: d91 and d96 denote time dummies for 1991 and 1996 respectively, IT denotes an interaction
term between AIDS and an OECD dummy variable, and dOECD denotes an OECD dummy variable.
Standard errors are in parentheses. It is assumed that g + δ =0 .05 as in MRW. All regressions are
estimated using OLS. White’s heteroskedasticity correction was used.
∗∗∗ Signiﬁcantly diﬀerent from
0 at the 1% level.
∗∗ Signiﬁcantly diﬀerent from 0 at the 5% level.
∗ Signiﬁcantly diﬀe r e n tf r o m0a t
the 10% level.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 14
time dummies, where d91 and d96 are dummy indicators for the years 1991 and 1996, respectively.19
These dummies are meant to captures exogenous shocks speciﬁct oe a c hﬁve-year period. The
results (column 3) are similar in terms of the magnitude and signiﬁcance level to those obtained
from estimating the model with BE. There is a slight decrease in the magnitude of the AIDS
coeﬃcient (−0.0047) but signiﬁcance increase to the 1% level.
To account for the possibility of country-speciﬁce ﬀects as well as time eﬀects, we estimate a
two-way ﬁxed-eﬀect speciﬁcation that involves the addition of 80 country-speciﬁc dummy variables
and 2 time dummy variables. However, as there are more coeﬃcients to estimate, we lose a large
number of degrees of freedom which clearly biases our estimates. This is obvious from the results
p r e s e n t e di nc o l u m n4a st h e r ei sas t a r kc hange in terms of the magnitude and signiﬁcance of the
coeﬃcient estimates. In particular, the estimate on ln(sitk) becomes insigniﬁcant, and the estimate
on ln(sith) changes from positive and signiﬁcant into negative and signiﬁcant. The coeﬃcient on
AIDS is still negative (−0.0008) but not signiﬁcantly diﬀerent from zero. We believe that these
radical changes in the estimates is due to the substantial loss of degrees of freedom. In addition, as
Griliches and Hausman (1986) note, in regressions using panel data with ﬁxed eﬀects speciﬁcations,
measurement error in the explanatory variables can lead to coeﬃcient estimates that are “too low”
and therefore insigniﬁcant; in controlling for the various ﬁxed eﬀects, the relative importance of
measurement errors in the explanatory variables becomes greatly exacerbated, biasing coeﬃcient
estimates.
I no r d e rt oa l l o wf o rt h ee ﬀect of AIDS to diﬀer among OECD and non-OECD countries, we
add an interaction term (IT) between AIDS and an OECD dummy variable (column 5). All of
the estimates are signiﬁcant and have the expected signs. In particular the key coeﬃcient estimate
for AIDS is −0.0040 and is signiﬁcant at the 5% level which corresponds with our cross-sectional
results. Finally, in addition to the interaction term, we include time speciﬁc dummies (d91 and
d96) to allow for the eﬀect of AIDS to diﬀer across time (column 6). The coeﬃcient estimate for
AIDS continues to be negative (−0.0046) but is now signiﬁcant only at the 10% level, whereas
the IT coeﬃcient estimate is positive and signiﬁcant at the 5% level and the dummy for OECD is
positive and signiﬁcant at the 1% level.
In summary, our panel estimation is generally supportive of our cross-sectional results. In
particular, with the exception of the model with ﬁxed and time eﬀects the impact of AIDS on
19In order to avoid perfect collinearity we drop the dummy variable on the ﬁrst ﬁve-year period.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 15
income obtained from the panel estimation is shown to be negative and similar in magnitude to
that obtained from our cross-sectional estimation.
4 Robustness
This section examines the robustness of our baseline results to alternative subsamples of AIDS
incidents by age group, and panel estimation that consider the problem of endogeneity.
4.1 AIDS by age groups
In addition to obtaining data on annual AIDS incidents, we were also able to assemble data on
the oﬃcially reported AIDS incidents for the period of study on diﬀerent age groups. In particular
we were able to disaggregate our original AIDS dataset into four age-group samples as follows:
AIDS[0-4] (infancy period), AIDS[5-15] (schooling period), AIDS[16-34] (productive period)a n d
AIDS[35-60+] (less productive period). Due to data constraints our original sample was reduced
from 89 to 63 countries.20
Some interesting observations become apparent from exploiting this dimension of our data.
Two of the four groups, AIDS[16-34] and AIDS[35-60+], are aﬀected most by the disease. More
precisely, the most aﬀected group in Africa is AIDS[16-34] which can have disastrous economic
consequences since it aﬀects people in their most productive stage of their lives. The same occurs
in Europe and Latin American countries like Argentina, Brazil and Mexico. Interestingly, and in
contrast to most countries, in the US the most aﬀected group is AIDS[35-60+].
Due to the high correlation between AIDS[0-4] and AIDS[16-34], 0.825, and AIDS[0-4] and
AIDS[16-34], 0.812, we decided to exclude AIDS[0-4] from our regression to reduce the possibility
of multicolinearity.21 Table 5 presents regression results using AIDS incidents by the three age
groups. The estimates on ln(sik), ln(sih)a n dl n ( ni + g + δ), are all signiﬁcant at the 1% level of
signiﬁcance with the expected sign. The main result from this exercise is that only the coeﬃcient
on AIDS[16-34] is signiﬁcant (albeit marginally at the 7% level) with a negative sign. It is also
important to notice that the magnitude of the AIDS[16-34] coeﬃcient estimate (−0.0961) has more
than doubled compared to respective cross-sectional estimate. This ﬁnding is quite intriguing as
20These countries are marked with an asterisk in Table A1 in Appendix A. A detailed explanation of how we
construct AIDS incidence by age group appears in Appendix C.
21This high correlation is present because infants till the age of 4 are infected almost exclusively by their parents
who are HIV positive or they are already infected by AIDS.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 16
Table 5: Cross-country regression using AIDS by age group
Dep. var.: ln(GDP per worker in 2000)

















Notes: Standard errors are in parentheses. It is assumed that g +δ =0 .05 as in MRW. All regressions
are estimated using OLS. White’s heteroskedasticity correction was used.
∗∗∗ Signiﬁcantly diﬀerent
from 0 at the 1% level.
∗∗ Signiﬁcantly diﬀerent from 0 at the 5% level.
∗ Signiﬁcantly diﬀerent from
0 at the 10% level.
it promotes the idea that the negative impact of AIDS on income is primarily due to arguably the
most productive age group, AIDS[16-34], being infected by AIDS.
4.2 Panel-IV estimation
Our regression model is potentially subject to the well-known endogeneity problem. A common
way to correct the endogeneity problem in much of the existing literature is to use instrumental
variables. However, as Islam (1995) and many subsequent papers have pointed out, it is diﬃcult to
come up with a set of “good” instruments that will be correlated with the potentially endogenous
variable (in our case AIDS) but not correlated with other regressors.22 An alternative solution to
22Nevertheless, we have considered instrumenting AIDS with initial AIDS in our cross-sectional analysis. How-
ever, since initial AIDS is very likely measured with very large errors (especially due to under-reporting), this can
substantially bias our estimates toward zero.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 17
the endogeneity problem is the use of panel data and in particular the use of lags of the right-hand
side variables as predetermined or weakly exogenous instruments in panel-data regressions.23,24
In this section we extend our panel data results presented in the previous section by using
instrumental variables (a panel-IV approach) to correct for the potential endogeneity of AIDS. In
particular, we use the ﬁrst lag of AIDS and schooling (sih) as instrumental variables for AIDS.
We use schooling because there are empirical and theoretical grounds to expect that past values of
human capital play an important role in explaining the eﬀect of AIDS on economic performance.25
The downside of this analysis is that our sample is reduced from 238 to 157 observations.
To examine the validity of our instruments we test the overidentifying restrictions for every
regression speciﬁcation considered in our panel-IV estimation. Results are presented in Panels A
and B in Table 6. For the speciﬁcations in column 2 and 3, the endogenous variable, AIDS, is
explained with two instruments; the ﬁrst lag of AIDS and the ﬁrst lag of schooling. This results
in one over-identifying restriction. For the next two speciﬁcations, presented in columns 4 and
5, in addition to AIDS we allow for another potentially endogenous variable; the interaction term
between AIDS and a dummy variable for OECD (IT). Therefore, as suggested by Woolridge (2002),
we include in our set of instruments an interaction term between a dummy variable for OECD and
the ﬁrst lag of AIDS.26 This, once again, results in one over-identifying restriction.
The ﬁrst row of Panel B in Table 6 reports the p-values from χ2 Sargan’s (1958) test. This is
a test of the joint null hypothesis that the excluded instruments are valid instruments. A rejection
casts doubt on the validity of the instruments. In all the speciﬁcations considered we fail to
reject the null of no correlation between the instruments and the error term, indicating that our
over-identifying instruments are satisfactory. In the bottom row of Panel B in Table 6 we use the
Hausman test to determine whether AIDS should be treated as exogenous or endogenous. In two
of the speciﬁcations, with dOECD and interaction term (column 4), and with dOECD, interaction
term and time eﬀe c t s ,w ea r ea b l et or e j e c tt h en u l la tt h e1 0 %l e v e lo fs i g n i ﬁcance that AIDS and
23The ﬁrst paper that examined cross-country regressions adjusting for both the ﬁxed-eﬀects problem as well as
for the endogeneity problem is Caselli et al. (1996).
24Despite these advantages, panel data with instrumental variable techniques have also been criticized for obtaining
estimates that are quite biased. For further discussion on these issues see Durlauf and Quah (1999), and Hauk and
Wacziarg (2004).
25See e.g., Corrigan, Glomm and Mendez (forthcoming), and Kalemli-Ozcan (2004).
26We thank Carter Hill who suggested to us this instrument. Ressler et al. (2002) use a similar instrument in an
attempt to test their hypothesis of a positive relationship between the size of welfare payments per recipient and the
heterosexual HIV infection rate in the United States.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 18
Table 6: Panel with Instrumental-Variable regressions
IV Regressions of ln(GDP per worker for 1985-1990, 1990-1995 and 1995-2000)
Speciﬁcation Panel A: Two Stage Least Squares
Non-oil with Non-oil with Non-oil with Non-oil with
time eﬀects time eﬀects & dOECD & time eﬀects,
country eﬀects interaction term dOECD &
interaction term
Constant 7.1240∗∗∗ 10.4529∗∗∗ 9.3990∗∗∗ 9.3595∗∗∗
(0.6595) (3.4310) (0.8114) (0.8043)
lnsitk 0.5965∗∗∗ −0.2999 0.5206∗∗∗ 0.5202∗∗
(0.0853) (0.2956) (0.0843) (0.0836)
ln(nit + g + δ) −1.4968 ∗∗∗ −0.2396 −0.5341∗ −0.5212∗
(0.2174) (0.5187) (0.3016) (0.2989)
lnsith 0.5862∗ 1.6255 0.5575∗∗∗ 0.5556∗∗∗
(0.0696) (2.8414) (0.0676) (0.0670)
AIDSit −0.0081∗∗∗ −0.0333 −0.0083∗∗∗ −0.0088∗∗∗
(0.0035) (0.0482) (0.0019) (0.0019)






Adj. R2 0.79 0.51 0.82 0.82
Obs. 157 157 157 157
Panel B: Speciﬁcation Tests (p-values)
Overidetifying 0.304 0.875 0.462 0.788
Restrictions
Hausman Test 0.177 0.993 0.064 0.052
Notes: d96 denotes a time dummy for 1996, IT denotes an interaction term between AIDS and an
OECD dummy variable, and dOECD denotes an OECD dummy variable. Standard errors are in
parentheses. It is assumed that g + δ =0 .05 as in MRW. All regressions are estimated using OLS.
White’s heteroskedasticity correction was used.
∗∗∗ Signiﬁcantly diﬀerent from 0 at the 1% level.
∗∗
Signiﬁcantly diﬀerent from 0 at the 5% level.
∗ Signiﬁcantly diﬀerent from 0 at the 10% level.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 19
the potentially endogenous interaction term are correlated with the error term. This implies that
we can apply Two Stage Least Squares (2SLS) and correct for endogeneity. For the speciﬁcations
in columns 2 and 3 we are not able to reject the null.
To evaluate the quality of our instruments, we further test their validity by estimating reduced
form regressions of AIDS on the explanatory instrumental variables. Subsequently we test the joint
signiﬁcance of the coeﬃcients on the instruments in each of our speciﬁcations. In all the regressions,
we reject the null hypothesis of zero coeﬃcients at the 1% level of signiﬁcance. This shows that our
instruments provide useful information in addition to that provided by the explanatory variables.
The panel-IV results are presented in Panel A of Table 6. In all speciﬁcations, the coeﬃcients on
ln(sitk),ln(sith)a n dl n ( nit +g +δ), as well as the 1996 dummy variable (d96), the interaction term
(IT), and the OECD dummy variable (dOECD) are qualitatively similar to those obtained in the
panel estimation without instrumental variables. With the exception of the model with country
and time speciﬁce ﬀects (column 3), the coeﬃcient estimates for AIDS are negative and highly
signiﬁcant, and in fact larger in magnitude than previous results. Therefore these results provide
evidence suggesting that our baseline results are robust to correcting for potential endogeneity.
4.3 Endogenous sample splitting
Following the emerging literature on parameter heterogeneity in cross-country regressions we are
able to examine whether AIDS is a threshold variable.27 In particular, we employ Hansen’s (2000)
splitting methodology and allow the data to endogenously select regimes using AIDS as a potential
threshold variable.28 The advantage of Hansen’s methodology over the regression-tree methodology
used in Durlauf and Johnson (1995) is that it is based on an asymptotic distribution theory. Our
threshold estimation uses the Solow level regression equation (1).29
In the ﬁrst round of splitting the bootstrap p-value was 0.008, implying that there may be
a sample split based on AIDS. The threshold estimate was γ =3 .0637 with asymptotic 95%
conﬁdence set [0.0734,7.4395]. AIDS as a threshold divided the full sample (89 countries) into two
subsamples: one, containing 50 countries (AIDS ≤ 3.0637) and another, with 39 countries (AIDS
27Papers in this literature include, Durlauf and Johnson (1995), Liu and Stengos (1999), Durlauf, Kourtellos and
Minkin (2001), Kalaitzidakis et al. (2001), and Masanjala and Papageorgiou (2004), just to name a few. For a more
comprehensive discussion on parameter heterogeneity see Durlauf and Quah (1999, Vol. 1, Ch. 4), and Durlauf,
Johnson and Temple (forthcoming, Part II, Ch. 7), and references therein.
28We use average AIDS (1979-2000) rather than initial AID Sb e c a u s ew ee x p e c ti n i t i a lA I D Sd a t at ob em u c hm o r e
prone to measurement error than subsequent periods.
29The GAUSS programs used for threshold estimation are available from the authors upon request.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 20
Figure 3: Regression tree diagram
> 3.0637).
We tried to further split the group with the higher AIDS incidence (AIDS > 3.0637), but the
bootstrap test statistic was insigniﬁcant. However, the bootstrap test statistic for the sample with
50 countries with AIDS ≤ 3.0637 was signiﬁcant (0.035), showing a possible sample split. More
precisely, γ =0 .0734 and the conﬁdence set is [0.0360,0.4024]. This implies that AIDS further
splits our subsample into two additional regimes: one, with 11 countries (AIDS ≤ 0.0734) and
another, with 39 countries (AIDS > 0.0734). No more splits were possible using the new regimes
as we obtained bootstrap test statistics that were insigniﬁcant.
Figure 3 presents a regression tree diagram that illustrates these results. Non-terminal nodes
are illustrated by squares whereas terminal nodes are illustrated by circles. The numbers inside
the squares and circles show the number of countries in each node. The point estimates for the
threshold variable are presented on the rays connecting the nodes. Table E1 in Appendix E presents
the countries included in each of the three regimes.
In general we interpret our threshold estimation results as further evidence of parameter het-
erogeneity; countries can be grouped according to diﬀerent statistical models. More importantly,
we have shown evidence supporting the idea that AIDS is a threshold variable.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 21
Table 7: Cost of AIDS in selected countries
Notes: All of the values are for the year 2000.
5 Discussion
Summary of results: Our results can be summarized as follows: a) When using the full sample of 89
countries we ﬁnd a negative and statistically signiﬁcant eﬀect of AIDS on cross-country per worker
income. b) When we arbitrarily split our entire sample into OECD and non-OECD subsamples the
negative relationship continues to exist when using the non-OECD subsample but vanishes in the
OECD subsample. c) When using AIDS incidents by age group we ﬁnd that there exists quantiﬁable
negative impact of AIDS on income only for people in the ages 16-34. d) Panel estimation results
(without or with instrumental variables) are consistent with those obtained in the cross-sectional
analysis. e) Using Hansen (2000) we also ﬁnd that AIDS is a threshold variable that can split our
full sample into four regimes obeying diﬀerent statistical models.
Interpretation of results: Beyond the negative impact of AIDS on income that emerges from our
estimation results it is important to examine the magnitude of this impact. It works out that the
coeﬃcient estimates for AIDS from various alternative estimation speciﬁcations (cross-sectional,
panel) and samples (full, non-OECD) are surprisingly quite stable at around −0.003 to −0.004.
This implies that for the period 1979-2000 each additional AIDS incident per 100,000 people per
year was associated with a 0.003 to 0.004 percentage point reduction income per worker income.
Using the most conservative AIDS estimate of −0.003 we are able to back out “lower bound”
cost estimates for the epidemic. Table 7 reports total cost to GDP ratio, cost per worker, costWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 22
per capita, and cost per new case in year 2000 for nine non-OECD countries grouped in three
categories by AIDS severity. As expected the total cost to GDP ratio varies with the epidemic’s
severity across countries (column 4). In particular, total cost to GDP ratio was 0.23% for Botswana
with the second highest incidence rate in our sample, whereas the same ratio was only 0.0001% for
South Korea. Cost per worker and cost per capita (columns 5-6) indicate the diﬀerence in individual
welfare loss in countries with a range of AIDS incidence. Finally, the last column reports estimates
of the cost per case in selected countries. Cost per case calculated using our estimates increases
with AIDS incidence but also with per capita income. For example even though AIDS incidence is
m u c hl o w e ri nH o n gK o n g( 0 .0494/100,000) than in Botswana (57.084/100,000), the cost per case
is more than three times higher in the former than the later country. Of course, thinking about
these estimates in relation to individual welfare would be the appropriate metric for this exercise.
Overall, these calculations show that the impact of AIDS vary dramatically across countries in our
sample and can have devastating eﬀects especially in those countries with high incidence but low
per capita income.
Reconciling our results with those of Bloom and Mahal (1997):I na ni n ﬂuential paper Bloom
and Mahal (1997) reach the conclusion that “... there is more ﬂash than substance to the claim
that AIDS impedes national economic growth.” A criticism of this paper is that given the scarcity
of the data used (authors use estimated AIDS cases for 51 countries for the period 1980-1992) it
is too early to tell what the impact of AIDS on growth may be. In addition to the problem of
data scarcity, it is the problem of quality of early data on HIV/AIDS which forced the authors to
resort to estimates of AIDS cases using epidemiological models. Even though measurement errors
associated with HIV/AIDS data are likely to be large primarily due to lack of adequate reporting,
early on these errors are very likely to be signiﬁcantly larger.
Given the severe criticism of this paper in the literature and public media we decided to reexam-
ine Bloom and Mahal’s result using our data and model speciﬁcation. More precisely, in addition
to the level regressions, we examine the eﬀect of AIDS on growth of GDP per worker for the period
1979-2000. We present the results of this exercise in Table F1 in Appendix F. It is shown that
standard growth regressors (lnyi0, ln(sik), ln(sih)a n dl n ( ni+g+δ)) in the alternative samples and
speciﬁcations considered are consistent with those obtained in other growth regressions commonly
found in the literature. When we include AIDS in the regressions, the AIDS coeﬃcients are found
not to be signiﬁcantly diﬀerent from zero for the full and non-OECD samples. For the OECDWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 23
sample the coeﬃcient is positive and signiﬁcant which may indicates an endogeneity problem being
present. In general, these results suggest that AIDS has an insigniﬁcant impact on cross-country
growth and therefore are supportive of the evidence and main conclusion in Bloom and Mahal
(1997).
This then leads us to the key question: How can it be that the Bloom and Mahal results hold,
indicating an insigniﬁcant impact of AIDS on growth, yet in our host of level regressions AIDS
is robustly negatively related with income? The diﬀerence in the two results comes down to the
central question asked; on the one hand, we are interested in the eﬀect of AIDS on income, thinking
that income is a good proxy for welfare. On the other hand Bloom and Mahal were interested in
the eﬀect of AIDS on growth, thinking that growth is a good proxy for the development process.
Our analysis suggests that the only criticism that Bloom and Mahal (1997) may be subject to is
that by using per worker income growth as the dependent variable the potential eﬀect of AIDS on
aggregate output may be masked (see Hall and Jones (1999, p.85)).
Limitations: Our work is certainly not without limitations. Even though one can point to
other caveats we want to focus on limitations due to quality and quantity of our AIDS dataset.
We recognize that the quality of the UNAIDS/WHO data is questionable on the grounds of cross-
country comparability, variable under-reporting and other methodological issues relating to data
collection and the deﬁnition of AIDS. In addition, we admit that AIDS epidemic is still a transitory
phenomenon and therefore as more data become available we will be in a better position to reach
more deﬁnite conclusions about its eﬀect on income.
6C o n c l u s i o n
In this paper, we investigate the impact of AIDS on cross-country income levels. Contrary to
previous work on AIDS, we make use of the oﬃcially reported AIDS incidents from UNAIDS/WHO
on 89 countries for the period 1979-2000, during which the AIDS epidemic has spread across the
world.
Using the extended Solow model as the basis of our empirical analysis we ﬁrst show that in the
full sample and non-OECD subsample, the coeﬃcient estimate for AIDS is negative and marginally
signiﬁcant. For the OECD countries, we obtain an insigniﬁcant coeﬃcient estimate, which implies
that AIDS has no quantiﬁable eﬀect on the income level for these countries. We also utilize the timeWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 24
dimension of our data and employ panel-data techniques on the extended Solow model with AIDS
as a regressor. AIDS enters negative and highly signiﬁcant in all of the speciﬁcations considered
except from the speciﬁcation with country and time eﬀects, where the estimate is insigniﬁcant.
Regression analysis using AIDS by age group reveals that only the coeﬃcient on AIDS between
the ages 16-34 is signiﬁcant with a negative sign. In addition, the magnitude of the AIDS[16-34]
coeﬃcient estimate has more than doubled compared to that obtained when using the aggregated
AIDS data. Finally, we employ Hansen’s (2000) threshold methodology that attempts to endoge-
nously split countries in diﬀerent regimes. This methodology successfully identiﬁes AIDS as a
threshold variable. An extensive robustness analysis establishes robustness of our baseline results
to various alternative speciﬁcations and subsamples.
Obviously, we do not claim to have the last word on the eﬀect of the AIDS epidemic on income
but merely to have shed new light on the eﬀects of an unraveling epidemic.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 25
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Appendix A
Table A1: Data used in the extended Solow model
Country PWT Code Mean values for relevant variables
Y/L I/Y SCHOOL n + g + δ AIDS
Algeria∗ DZA 10005.4 13.65 0.0825 0.0811 0.1165
Angola AGO 4360.1 6.35 0.0241 0.0759 3.5434
Argentina∗ ARG 18742.5 15.89 0.0859 0.0647 2.6654
Australia AUS 40452.0 23.98 0.1108 0.0633 2.8723
Austria∗ AUT 36615.7 25.61 0.1075 0.0556 1.4293
Bangladesh BGD 3046.7 10.30 0.0381 0.0709 0.0009
Belgium∗ BEL 38061.8 23.13 0.1094 0.0515 1.6902
Benin BEN 2406.2 7.19 0.0252 0.0795 5.4167
Bolivia∗ BOL 5205.1 9.01 0.0646 0.0739 0.2169
Botswana BWA 14769.7 17.38 0.0635 0.0790 57.0842
Brazil∗ BRA 11723.9 17.34 0.0587 0.0716 7.4395
Burkina Faso∗ BFA 2051.0 11.25 0.0073 0.0725 11.2315
Burundi BDI 1248.1 6.07 0.0066 0.0698 27.4842
Cameroon CMR 4321.1 6.64 0.0345 0.0772 10.8619
Canada∗ CAN 42080.2 24.97 0.1155 0.0614 3.0637
C.African Rep. CAF 2357.0 5.11 0.0191 0.0708 20.3963
Chad∗ TCD 1903.4 6.63 0.0108 0.0745 12.7695
Chile∗ CHL 16137.4 18.79 0.0941 0.0657 1.7143
Colombia∗ COL 9276.3 12.14 0.0834 0.0733 1.5264
Congo COG 5024.4 7.48 0.1059 0.0771 168.5997
Costa Rica∗ CRI 9391.8 16.04 0.0806 0.0776 3.4051
Denmark∗ DNK 42759.9 22.52 0.1151 0.0532 2.4675
Dom. Rep.∗ DOM 9089.1 13.43 0.0764 0.0731 4.2897
Ecuador∗ ECU 6051.4 15.90 0.0917 0.0785 0.7835
Egypt∗ EGY 7282.9 6.06 0.1082 0.0756 0.0295
El Salvador∗ SLU 7778.1 7.85 0.0525 0.0732 3.2685
Ethiopia ETH 1388.1 4.27 0.0179 0.0733 7.1639
Finland∗ FIN 36433.6 24.42 0.1164 0.0525 0.3876
France∗ FRA 36165.8 24.60 0.1065 0.0549 4.8720
Ghana∗ GHA 2464.5 6.08 0.0678 0.0826 16.6795
Greece∗ GRC 23087.6 21.53 0.0968 0.0556 1.2263
Guatemala∗ GTM 8202.7 7.40 0.0350 0.0768 2.2228
Haiti HTI 6235.0 5.31 0.0256 0.0724 8.1973
Honduras∗ HND 3947.2 14.48 0.0503 0.0820 13.2563
Hong Kong∗ HKG 38179.1 25.05 0.0859 0.0674 0.4939
India IND 4360.6 12.35 0.0609 0.0710 0.0734
Indonesia∗ IDN 6263.5 17.76 0.0629 0.0717 0.0159
Ireland∗ IRL 40520.7 19.79 0.1453 0.0616 1.0947
Israel∗ ISR 30942.5 26.60 0.1163 0.0794 0.8832
Italy∗ ITA 33816.6 22.27 0.0836 0.0528 4.5305
Jamaica∗ JAM 5648.5 17.72 0.1233 0.0660 11.1127
Japan∗ JPN 38057.5 32.56 0.1038 0.0531 0.0950
Jordan∗ JOR 7490.8 15.15 0.1548 0.0998 0.1469
Kenya KEN 2451.1 8.07 0.0417 0.0853 24.9535
Korea∗ KOR 20719.5 36.29 0.1261 0.0644 0.0306
Notes: The sources for these data are Bernanke and G¨ urkaynak (2001), UNAIDS/WHO and PWT 6.1.
* denotes the 63 nations included in the sample used to carry out age-sepciﬁc AIDS estimation.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 29
Table A1: Data used in the extended Solow model (cont.)
Country PWT Code Mean values for relevant variables
Y/L I/Y SCHOOL n + g + δ AIDS
Madagascar∗ MDG 1677.6 3.03 0.0383 0.0769 0.0211
Malawi MWI 1591.9 7.92 0.0147 0.0735 40.9708
Malaysia MYS 15251.6 26.56 0.0906 0.0777 1.6425
Mali MLI 1995.9 8.23 0.0162 0.0730 3.7066
Mauritania MRT 2984.3 8.70 0.0201 0.0779 2.0821
Mauritius∗ MUS 21132.0 12.52 0.0808 0.0643 0.4024
Mexico∗ MEX 15629.6 17.49 0.0953 0.0759 2.9271
Morocco∗ MAR 7024.9 11.95 0.0547 0.0746 0.2073
Mozambique MOZ 2107.5 3.41 0.0112 0.0672 9.8234
Netherlands∗ NLD 37847.2 22.58 0.1226 0.0564 1.8466
New Zealand∗ NZL 30608.2 22.20 0.1223 0.0605 1.1704
Nicaragua∗ NIC 3584.3 12.41 0.0775 0.0810 0.4314
Niger∗ NER 1875.0 4.61 0.0091 0.0816 4.2395
Nigeria NGA 1592.5 9.39 0.0330 0.0778 3.1480
Norway∗ NOR 49423.1 28.65 0.1129 0.0555 0.9070
Pakistan∗ PAK 3956.5 11.14 0.0359 0.0736 0.0112
Panama∗ PAN 10528.0 18.78 0.1079 0.0736 7.7935
Papua N.G.∗ PNG 5778.8 10.35 0.0218 0.0762 1.5274
Paraguay∗ PRY 8423.9 12.70 0.0558 0.0800 0.6948
Peru∗ PER 7767.1 17.62 0.1068 0.0747 2.3352
Philippines PHL 6896.7 14.36 0.1239 0.0754 0.0420
Portugal∗ PRT 25241.1 23.10 0.0836 0.0538 4.8888
Rwanda RWA 1839.0 4.64 0.0101 0.0773 18.5401
Senegal SEN 3161.3 6.71 0.0258 0.0766 2.5547
Sierra Leone SLE 1388.0 4.85 0.0258 0.0701 0.5959
Singapore∗ SGP 40393.7 42.45 0.0971 0.0741 1.3665
Spain∗ ESP 27861.2 24.47 0.1157 0.0553 8.4116
Sri Lanka∗ LKA 5695.3 12.34 0.1030 0.0677 0.0467
Sweden∗ SWE 38254.8 21.12 0.0960 0.0535 1.1200
Switzerland∗ CHE 41885.1 27.79 0.0946 0.0562 5.6556
Syria∗ SYR 7742.7 9.17 0.1052 0.0875 0.0360
Tanzania∗ TZA 932.4 16.46 0.0079 0.0815 26.0605
Thailand∗ THA 9858.3 32.98 0.0570 0.0685 17.0469
Togo∗ TGO 1760.4 8.12 0.0425 0.0782 21.9104
Tri.&Tobago∗ TTO 20072.5 9.39 0.1175 0.0642 21.9104
Tunisia TUN 11064.1 13.26 0.0695 0.0758 0.4423
Turkey∗ TUR 11548.5 18.80 0.0740 0.0716 0.0376
Uganda UGA 2132.7 13.65 0.0172 0.0753 19.1190
UK∗ GBR 37153.1 18.77 0.0998 0.0531 1.6040
Uruguay∗ URY 16503.9 10.76 0.0907 0.0565 2.8308
USA∗ USA 53979.1 21.29 0.1163 0.0603 14.8092
Venezuela VEN 11757.8 14.30 0.0686 0.0771 2.6470
Zambia ZMB 1664.6 8.94 0.0367 0.0774 39.7673
Zimbabwe ZWE 5053.0 13.49 0.0577 0.0752 55.4721
Notes: The sources for these data are Bernanke and G¨ urkaynak (2001), UNAIDS/WHO and PWT 6.1.
* denotes the 63 nations included in the sample used to carry out age-speciﬁc AIDS estimation.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 30
Appendix B
AIDS Deﬁnition
In a meeting convened in Geneva by the WHO Global Programme on AIDS (1994) was suggested
the following: the 1985 provisional WHO clinical case deﬁnition for AIDS (“Bangui deﬁnition”) to
be referred to as the WHO AIDS surveillance case deﬁnition and it was introduced an expanded
WHO AIDS surveillance case deﬁnition. (Weekly Epidemiological Record, 1994, issue 69, pp.
273-280).
1. WHO case deﬁnition for AIDS surveillance
For the purposes of AIDS surveillance an adult or adolescent (> 12 years of age) is considered
to have AIDS if at least 2 of the following major signs are present in combination wit hat least 1 of
the minor signs listed below, and if these signs are not known to be due to a condition unrelated
to HIV infection.
Major signs
- weight loss  10% of body weight
- chronic diarrhoea for more than 1 month
- prolonged fever for more than 1 month (intermittent or constant)
Minor signs
- persistent cough for more than 1 month
- generalized pruritic dermatitis
- history of herpes zoster
- oropharyngeal candidiasis
- chronic progressive or disseminated herpes simplex infection generalized lymphadenopathy
The presence of either generalized Kaposi sarcoma or cryptococcal meningitis is suﬃcient for
the diagnosis of AIDS for surveillance purposes.
2. Expended WHO case deﬁnition for AIDS surveillance
For the purposes of AIDS surveillance an adult or adolescent (> 12 years of age) is considered
to have AIDS if a test for HIV antibody gives a positive result, and 1 or more of the following
conditions are present:
-  10% body weight loss or cachexia, with diarrhoea or fever, or both, intermittent or constant,
for at least 1 month, not known to be due to a condition unrelated to HIV infection
- cryptococcal meningitis
- pulmonary or extra-pulmonary tuberculoses
- Kaposi sarcoma
- neurological impairment that is suﬃcient to prevent independent daily activities, not known
to be due to a condition unrelated to HIV infection (for example, trauma or cerebrovascular
accident)
- candidiasis of the oesophagus (which may be presumptively diagnosed based on the presence
of oral candidiasis accompanied by dysphagia)
- clinically diagnosed life-threatening or recurrent episodes of pneumonia, with or without
etiological conﬁrmation
- invasive cervical cancerWhat Do We Know About the Impact of AIDS on Cross-Country Income So Far? 31
Appendix C
Constructing the AIDS cases by age
-T h eo ﬃcially reported AIDS cases for the diﬀerent age groups are reported as a total before
1997 and annually for 1997, 1998, 1999 and 2000.
- In addition to the oﬃcially reported cases per age group, UNAIDS/WHO also reports “Not
speciﬁed/unknown cases” (NS).
- Although the data in the OECD countries have very few NS cases, the data in many low-income
countries like sub-Saharan Africa countries contain a lot of NS cases.
- We can not use NS cases in our calculation of the age groups and recognize that this is a
source of measurement error due to aggregation.
- We chose aggregate AIDS cases into four age-group samples as follows: AIDS[0-4] (infancy
period), AIDS[5-15] (schooling period), AIDS[16-34] (productive period) and AIDS[35-60+] (less
productive period).
- We divide the total number of reported AIDS cases in each age group by the number of years
cases are reported and multiply by 100,000 and divide by average population. This the mean AIDS
cases reported per 100,000 people by each of the four age groups.
- Data on population are taken for the WDI (2002). We start from the year, during which an
AIDS case was reported till 2000.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 32
Appendix D
Excluding potential outliers
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Notes: The plot above includes 84 countries. We exclude Botswana, Congo, Malawi, Zimbabwe,
Zambia with very high AIDS incidents.
Table D1: Cross-country regressions
Dependent variable: ln(GDP per worker in 2000)
Speciﬁcation Extended Solow model with AIDS
(PWT 6.1 − WHO 2002)
Non-oil OECD Non-OECD
Constant 4.5334∗∗∗ 10.0434∗∗∗ 5.8110∗∗∗
(0.9542) (2.0069) (1.5857)
lnsik 0.6092∗∗∗ 0.5142 0.5874∗∗∗
(0.1267) (0.3173) (0.1386)
ln(ni + g + δ) −2.7933∗∗∗ −1.3294∗∗ −2.2245∗∗∗
(0.3017) (0.5799) (0.6147)
lnsih 0.5575∗∗∗ 1.2162∗∗∗ 0.5078∗∗∗
(0.0945) (0.2401) (0.0991)
AIDS −.0141 0.0247 −0.0188∗∗
(0.0094) (0.0174) (0.0094)
Adj. R2 0.86 0.66 0.75
Obs. 84 21 63
Notes: Standard errors are in parentheses. It is assumed that g +δ =0 .05 as in MRW. All regressions
are estimated using OLS. White’s heteroskedasticity correction was used.
∗∗∗ Signiﬁcantly diﬀerent
from 0 at the 1% level.
∗∗ Signiﬁcantly diﬀerent from 0 at the 5% level.
∗ Signiﬁcantly diﬀerent from
0 at the 10% level.What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 33
Appendix E
Table E1: Countries in three regimes
Regime 1 Regime 2 Regime 3
Angola Kenya Algeria Mauritania Bangladesh
Benin Malawi Argentina Mauritius Egypt
Botswana Mali Australia Mexico India
Brazil Mozambique Austria Morocco Indonesia
Burkina Faso Niger Belgium Netherlands Korea
Burundi Nigeria Bolivia New Zealand Madagascar
Cameroon Panama Chile Nicaragua Pakistan
C. Afr. Rep. Portugal Canada Norway Philippines
Chad Rwanda Columbia Papua N.G. Sri Lanka
Congo Spain Denmark Paraguya Syria
Costa Rica Switzerland Ecuador Peru Turkey
Dom. Rep. Tanzania Finland Senegal
El Salvador Thailand Greece Sierra Leone
Ethiopia Togo Guatemala Singapore
France Tri.&Tobago Hong Kong Sweden
Ghana Uganda Ireland Tunisia
Haiti USA Israel UK
Honduras Zambia Japan Uruguay
Italy Zimbabwe Jordan Venezuela
Jamaica Malaysia
(39) (39) (11)What Do We Know About the Impact of AIDS on Cross-Country Income So Far? 34
Appendix F
Growth Regressions
Table F1: Growth regressions for the full sample and OECD and non-OECD subsamples
Dependent variable: Growth GDP per worker (initial-2000)
Speciﬁcation Extended Solow Model Extended Solow Model with AIDS
(PWT 6.1) (PWT6.1 − WHO 2000)
Non-oil OECD Non-OECD Non-oil OECD Non-OECD
Constant 1.8918 2.7079 1.9609 1.9513 2.9759 2.0686
(1.6168) (1.6568) (2.3318) (1.6465) (1.8789) (2.3836)
lnyi0 −0.4544∗∗ −0.1285 −0.4748∗∗ −0.4600∗∗ −0.1758 −0.4823∗∗
(0.1976) (0.1565) (0.2111) (0.2016) (0.1596) (0.2165)
lnsik 0.4606∗∗∗ −0.2290 0.4677∗∗∗ 0.4585∗∗∗ −0.1776 0.4649∗∗∗
(0.1568) (0.2180) (0.1546) (0.1570) (0.2261) (0.1547)
ln(ni + g + δ) −1.6132∗∗∗ −0.1404 −1.6480∗∗∗ −1.6133∗∗∗ −0.2232 −1.6373∗∗∗
(0.3948) (0.4732) (0.4601) (0.3972) (0.4031) (0.4602)
lnsih 0.3058∗∗ 0.6203∗∗∗ 0.3010∗∗ 0.3092∗∗ 0.6333∗∗ 0.3056∗∗
(0.1337) (0.2013) (0.1394) (0.1365) (0.2395) (0.1430)
AIDS −0.0008 0.0176∗∗ −0.0009
(0.0013) (0.0073) (0.0015)
Adj. R2 0.50 0.36 0.45 0.50 0.52 0.45
Obs. 89 21 68 89 21 68
Notes: Standard errors are in parentheses. It is assumed that g +δ =0 .05 as in MRW. All regressions
are estimated using OLS. White’s heteroskedasticity correction was used.
∗∗∗ Signiﬁcantly diﬀerent
from 0 at the 1% level.
∗∗ Signiﬁcantly diﬀerent from 0 at the 5% level.
∗ Signiﬁcantly diﬀerent from
0 at the 10% level. Investment and population growth rates are averages for the period 1979-2000. sh
is the average percentage of the working-age population in secondary school for the period 1970-1995.